ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Tecentriq 840 mg/14 ml, Konzentrat zur Herstellung einer Infusionslösung - 
66152002 Roche Pharma (Schweiz) AG
Tecentriq 840 mg/14 ml, Konzentrat zur Herstellung einer Infusionslösung23.05.2017
  21.05.2019
(L01FF05) 
WHO-DDD 
07.16.10. 
07.16.10. 
A  
No 
IP 
PR  
k.A.PR
  
7680661520029Biotechnologika
  
Composition
atezolizumabum 840 mg, histidinum, acidum aceticum glaciale, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 14 ml.
Packungsbestandteile
Concentrate for infusion
 
 
Active AgentDose
Atezolizumabum840mg / 14ml
 
Inactive agents
Acidum Aceticum Glaciale
Histidine
Polysorbatum 20
Saccharum
Source
Data was imported : 06.04.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home